These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
184 related articles for article (PubMed ID: 11850545)
1. Quantification of MYCN, DDX1, and NAG gene copy number in neuroblastoma using a real-time quantitative PCR assay. De Preter K; Speleman F; Combaret V; Lunec J; Laureys G; Eussen BH; Francotte N; Board J; Pearson AD; De Paepe A; Van Roy N; Vandesompele J Mod Pathol; 2002 Feb; 15(2):159-66. PubMed ID: 11850545 [TBL] [Abstract][Full Text] [Related]
2. Relationship of DDX1 and NAG gene amplification/overexpression to the prognosis of patients with MYCN-amplified neuroblastoma. Kaneko S; Ohira M; Nakamura Y; Isogai E; Nakagawara A; Kaneko M J Cancer Res Clin Oncol; 2007 Mar; 133(3):185-92. PubMed ID: 17028906 [TBL] [Abstract][Full Text] [Related]
3. Quantitative real-time PCR for quick simultaneous determination of therapy-stratifying markers MYCN amplification, deletion 1p and 11q. Boensch M; Oberthuer A; Fischer M; Skowron M; Oestreich J; Berthold F; Spitz R Diagn Mol Pathol; 2005 Sep; 14(3):177-82. PubMed ID: 16106200 [TBL] [Abstract][Full Text] [Related]
4. Coamplification of DDX1 correlates with an improved survival probability in children with MYCN-amplified human neuroblastoma. Weber A; Imisch P; Bergmann E; Christiansen H J Clin Oncol; 2004 Jul; 22(13):2681-90. PubMed ID: 15226335 [TBL] [Abstract][Full Text] [Related]
5. Concomitant DDX1 and MYCN gain in neuroblastoma. Defferrari R; Tonini GP; Conte M; Papio F; Sementa AR; Valent A; Schena F; Perri P; Mazzocco K Cancer Lett; 2007 Oct; 256(1):56-63. PubMed ID: 17611020 [TBL] [Abstract][Full Text] [Related]
6. Clinical significance of a highly sensitive analysis for gene dosage and the expression level of MYCN in neuroblastoma. Tanaka S; Tajiri T; Noguchi S; Shono K; Ihara K; Hara T; Suita S J Pediatr Surg; 2004 Jan; 39(1):63-8. PubMed ID: 14694373 [TBL] [Abstract][Full Text] [Related]
7. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma. Squire JA; Thorner PS; Weitzman S; Maggi JD; Dirks P; Doyle J; Hale M; Godbout R Oncogene; 1995 Apr; 10(7):1417-22. PubMed ID: 7731693 [TBL] [Abstract][Full Text] [Related]
8. Clinical implications of a slight increase in the gene dosage of MYCN in neuroblastoma determined using quantitative PCR. Souzaki R; Tajiri T; Higashi M; Kinoshita Y; Tanaka S; Kohashi K; Tsuneyoshi M; Taguchi T Pediatr Surg Int; 2008 Oct; 24(10):1095-100. PubMed ID: 18726105 [TBL] [Abstract][Full Text] [Related]
9. Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial carcinomas. Karlsson A ; Helou K; Walentinsson A; Hedrich HJ; Szpirer C; Levan G Genes Chromosomes Cancer; 2001 Aug; 31(4):345-56. PubMed ID: 11433525 [TBL] [Abstract][Full Text] [Related]
10. Expression of two dead box genes (DDX1 and DDX6) is independent of that of MYCN in human neuroblastoma cell lines. Akiyama K; Akao Y; Yokoyama M; Nakagawa Y; Noguchi T; Yagi K; Nishi Y Biochem Mol Biol Int; 1999 Apr; 47(4):563-8. PubMed ID: 10319407 [TBL] [Abstract][Full Text] [Related]
11. Rapid and accurate determination of MYCN copy number and 1p deletion in neuroblastoma by quantitative PCR. Anderson J; Gibson S; Williamson D; Rampling D; Austin C; Shipley J; Sebire N; Brock P Pediatr Blood Cancer; 2006 Jun; 46(7):820-4. PubMed ID: 16220551 [TBL] [Abstract][Full Text] [Related]
12. Genes co-amplified with MYCN in neuroblastoma: silent passengers or co-determinants of phenotype? Scott D; Elsden J; Pearson A; Lunec J Cancer Lett; 2003 Jul; 197(1-2):81-6. PubMed ID: 12880964 [TBL] [Abstract][Full Text] [Related]
13. Amplification of a DEAD box gene (DDX1) with the MYCN gene in neuroblastomas as a result of cosegregation of sequences flanking the MYCN locus. Noguchi T; Akiyama K; Yokoyama M; Kanda N; Matsunaga T; Nishi Y Genes Chromosomes Cancer; 1996 Feb; 15(2):129-33. PubMed ID: 8834177 [TBL] [Abstract][Full Text] [Related]
14. Co-amplification and concomitant high levels of expression of a DEAD box gene with MYCN in human neuroblastoma. Manohar CF; Salwen HR; Brodeur GM; Cohn SL Genes Chromosomes Cancer; 1995 Nov; 14(3):196-203. PubMed ID: 8589036 [TBL] [Abstract][Full Text] [Related]
15. Copy number status and mutation analyses of anaplastic lymphoma kinase (ALK) gene in 90 sporadic neuroblastoma tumors. Bagci O; Tumer S; Olgun N; Altungoz O Cancer Lett; 2012 Apr; 317(1):72-7. PubMed ID: 22085494 [TBL] [Abstract][Full Text] [Related]
16. The DDX1 gene maps within 400 kbp 5' to MYCN and is frequently coamplified in human neuroblastoma. Amler LC; Schürmann J; Schwab M Genes Chromosomes Cancer; 1996 Feb; 15(2):134-7. PubMed ID: 8834178 [TBL] [Abstract][Full Text] [Related]
17. Real-time quantitative PCR as an alternative to Southern blot or fluorescence in situ hybridization for detection of gene copy number changes. Hoebeeck J; Speleman F; Vandesompele J Methods Mol Biol; 2007; 353():205-26. PubMed ID: 17332643 [TBL] [Abstract][Full Text] [Related]
18. Real-time quantitative PCR for the measurement of MYCN amplification in human neuroblastoma with the TaqMan detection system. Raggi CC; Bagnoni ML; Tonini GP; Maggi M; Vona G; Pinzani P; Mazzocco K; De Bernardi B; Pazzagli M; Orlando C Clin Chem; 1999 Nov; 45(11):1918-24. PubMed ID: 10545060 [TBL] [Abstract][Full Text] [Related]
19. Assessment of MYCN amplification in neuroblastoma biopsies by differential polymerase chain reaction. Boerner S; Squire J; Thorner P; McKenna G; Zielenska M Pediatr Pathol; 1994; 14(5):823-32. PubMed ID: 7808981 [TBL] [Abstract][Full Text] [Related]
20. The genetic and clinical significance of MYCN gain as detected by FISH in neuroblastoma. Souzaki R; Tajiri T; Teshiba R; Higashi M; Kinoshita Y; Tanaka S; Taguchi T Pediatr Surg Int; 2011 Mar; 27(3):231-6. PubMed ID: 21046119 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]